Abbott Laboratories (ABT)

EBITDA Margin

24.31%

TTM · Period ending:

ABT logo

ABT EBITDA Margin

Latest reported24.31%
ABT TTM EBITDA Margin (26.74% → 24.31%)
High-resolution chart · PNG

ABT ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Abbott Laboratories EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
29.0319%
30.7141%
30.7583%
30.5647%
29.649%
29.4266%
30.2579%
30.5952%
31.6191%
31.6228%
31.272%
31.2961%
31.0669%
30.6801%
30.1107%
29.8468%
29.9224%
29.7745%
29.9921%
30.4508%
30.4165%
30.1287%
29.4573%
28.651%
28.3585%
28.7574%
28.9942%
29.9636%
30.119%
29.1762%
28.6405%
27.1981%
27.3168%
24.8466%
24.8844%
25.4184%
25.0389%
28.0767%
28.1534%
28.0521%
28.101%
28.4598%
28.6116%
-24.3543%
-9.398%
6.1962%
22.6997%
26.6815%
25.283%
23.9706%
22.3212%
30.4732%
28.6892%
26.0317%
22.9198%
30.5463%
27.9884%
25.7711%
23.0749%
29.0797%
26.7385%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.